Actual Medicinal Product (AMP) -
COVID-19 Vaccine Bimervax (recombinant, adjuvanted) 40micrograms/0.5ml dose emulsion for injection multidose vials (Hipra Human Health S.L.U.)
Name Details
Current Name
COVID-19 Vaccine Bimervax (recombinant, adjuvanted) 40micrograms/0.5ml dose emulsion for injection multidose vials
|
Start Date
11-05-2023
|
End Date
|
|
Abbreviated Name
COVID-19 Vaccine Bimervax 0.5ml inj multidose vials
|
Start Date
11-05-2023
|
|
Summary
- Licensed Route
- Intramuscular
- Availability Restrictions
- Restricted Availability
- Licensing Authority
- Medicines - MHRA/EMA
- EMA Indicator
- EMA Monitoring
Codes
SNOMED Codes
Code
|
Start Date
|
End Date
|
41780111000001104 |
11-05-2023 |
|
Actual Medicinal Product Pack (AMPP) Information